ID   MKN1 CHRNB2 KO-1
AC   CVCL_C7NI
DR   Wikidata; Q117704707
RX   PubMed=34331011;
CC   Population: Japanese.
CC   Knockout cell: Method=CRISPR/Cas9; HGNC; HGNC:1962; CHRNB2.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
DI   NCIt; C5474; Gastric adenosquamous carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1415 ! MKN1
SX   Male
AG   72Y
CA   Cancer cell line
DT   Created: 21-03-23; Last updated: 19-12-24; Version: 4
//
RX   PubMed=34331011; DOI=10.1038/s41388-021-01945-9;
RA   Kanda, Mitsuro
RA   Shimizu, Dai
RA   Nakamura, Shunsuke
RA   Sawaki, Koichi
RA   Umeda, Shinichi
RA   Miwa, Takashi
RA   Tanaka, Haruyoshi
RA   Inokawa, Yoshikuni
RA   Hattori, Norifumi
RA   Hayashi, Masamichi
RA   Tanaka, Chie
RA   Nakayama, Goro
RA   Iguchi, Yohei
RA   Katsuno, Masahisa
RA   Kodera, Yasuhiro
RT   "Blockade of CHRNB2 signaling with a therapeutic monoclonal antibody
RT   attenuates the aggressiveness of gastric cancer cells.";
RL   Oncogene 40:5495-5504(2021).
//